Show simple item record

dc.contributor.authorLotfinegad, P
dc.contributor.authorShamsasenjan, K
dc.contributor.authorMovassaghpour, A
dc.contributor.authorMajidi, J
dc.contributor.authorBaradaran, B
dc.date.accessioned2018-08-26T06:06:07Z
dc.date.available2018-08-26T06:06:07Z
dc.date.issued2014
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/41941
dc.description.abstractImmunosuppressive ability of mesenchymal stem cells (MSCs), their differentiation properties to various specialized tissue types, ease of in vitro and in vivo expansion and specific migration capacity, make them to be tested in different clinical trials for the treatment of various diseases. The immunomodulatory effects of MSCs are less identified which probably has high clinically significance. The clinical trials based on primary research will cause better understanding the ability of MSCs in immunomodulatory applications and site specific migration in the optimization of therapy. So, this review focus on MSCs functional role in modulating immune responses, their ability in homing to tumor, their potency as delivery vehicle and their medical importance.
dc.language.isoEnglish
dc.relation.ispartofAdvanced pharmaceutical bulletin
dc.titleImmunomodulatory nature and site specific affinity of mesenchymal stem cells: a hope in cell therapy.
dc.typearticle
dc.citation.volume4
dc.citation.issue1
dc.citation.spage5
dc.citation.epage13
dc.citation.indexPubmed
dc.identifier.DOIhttps://doi.org/10.5681/apb.2014.002


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record